Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene

Cancer Research

Volumn 63, Issue 18, 2003, Pages 6004-6007

  Kawakami, Kazuyuki ^a   Watanabe, Go ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARMOFUR; DOXIFLURIDINE; FLUOROPYRIMIDINE; FLUOROURACIL; NUCLEOTIDE; THYMIDYLATE SYNTHASE; UFT;

ALLELE; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; ETHNOLOGY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PLASMID; PREDICTION; PRIORITY JOURNAL; RECTUM CARCINOMA; RNA TRANSLATION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; TANDEM REPEAT; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HELA CELLS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; TANDEM REPEAT SEQUENCES; THYMIDYLATE SYNTHASE;

EID: 0141507954     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Nagasubramanian, R., Innocenti, F., and Ratain, M. J. Pharmacogenetics in cancer treatment. Annu. Rev. Med., 54: 437-452, 2003.
2. Danenberg, P. V. Thymidylate synthetase - a target enzyme in cancer chemotherapy. Biochim. Biophys. Acta, 473: 73-92, 1977.
3. Danenberg, P. V., Malli, H., and Swensom, S. Thymidylate synthase inhibitors. Semin. Oncol., 26: 621-631, 1999.
4. Horie, N., Aiba, H., Oguro, K., Hojo. H., and Takeishi, K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct. Funct., 20: 191-197, 1995.
5. Kawakami, K., Omura, K., Kanehira, E., and Watanabe, Y. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res., 19: 3249-3252, 1999.
6. Iacopetta, B., Grieu, F., Joseph, D., and Elsaleh, H. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br. J. Cancer, 85: 827-830, 2001.
7. Marsh, S., McKay, J. A., Cassidy, J., and McLeod, H. L. Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer, Int. J. Oncol., 19: 383-386, 2001.
8. Pullarkat, S. T., Stoehlmacher, J., Ghaderi, V., Xiong, Y. P., Ingles, S. A., Sherrod, A., Warren, R., Tsao-Wei, D., Groshen. S., and Lenz, H. J. Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J., 1: 65-70, 2001.
9. Villafranca, E., Okruzhnov, Y., Dominguez, M. A., Garcia-Foncillas, J., Azinovic, I., Martinez, E., Illarramendi, J. J., Arias, F., Martinez Monge, R., Salgado, E., Angeletti, S., and Brugarolas, A. Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer. J. Clin. Oncol., 19: 1779-1786, 2001.
10. Kawakami. K., Salonga, D., Park, J. M., Danenberg, K. D., Uetake, H., Brabender, J., Omura, K., Watanabe. G., and Danenberg, P. V. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin. Cancer Res., 7: 4096-4101, 2001.
11. Kawakami, K., Ishida, Y., Danenberg, K. D., Omura. K., Watanabe, G., and Danenberg, P. V. Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity. Jpn. J. Cancer Res., 93: 1221-1229, 2002.
12. Etienne, M. C., Chazal, M., Laurent-Puig, P., Magne, N., Rosty, C., Formento, J. L., Francoual, M., Formento, P., Renee, N., Chamorey, E., Bourgeon, A., Seitz, J. F., Delpero, J. R., Letoublon, C., Pezet, D., and Milano, G. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses. J. Clin. Oncol., 20: 2832-2843, 2002.
13. Elsaleh, H., Joseph, D., Grieu. F., Zeps, N., Spry, N., and Iacopetta, B. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet., 355: 1745-1750, 2000.
14. Marsh, S., Collie Duguid, E. S., Li, T., Liu, X., and McLeod, H. L. Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations. Genomics, 58: 310-312, 1999.
15. Breivik, J., Lothe, R. A., Meling, G. I., Rognum, T. O., Borresen-Dale. A. L., and Gaudernack. G. Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int. J. Cancer, 74: 664-669, 1997.
16. Wiencke, J. K., Zheng, S., Lafuente, A., Lafuente, M. J., Grudzen, C., Wrensch, M. R., Miike, R., Ballesta. A., and Trias, M. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol. Biomark. Prev., 8: 501-506, 1999.
17. Hawkins, N., Norrie, M., Cheong, K., Mokany, E., Ku, S. L., Meagher, A., O'Connor, T., and Ward, R. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology, 122: 1376-1387, 2002.
18. van Rijnsoever, M., Grieu, F., Elsaleh, H., Joseph, D., and Iacopetta, B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut, 51: 797-802, 2002.